Cover Image
市場調查報告書

韓國生物性骨材市場預測

South Korea Orthobiologics Market Outlook to 2021

出版商 GlobalData 商品編碼 297075
出版日期 內容資訊 英文 46 Pages
訂單完成後即時交付
價格
Back to Top
韓國生物性骨材市場預測 South Korea Orthobiologics Market Outlook to 2021
出版日期: 2015年09月11日 內容資訊: 英文 46 Pages
簡介

本報告提供韓國生物性骨材市場相關的人工骨替代材料,關節內補充劑,自體骨移植片,骨生長刺激植入裝置等各類別銷售額,彙整銷售數的實際成果及預測,平均價格,企業佔有率,流通佔有率,再加上主要企業簡介,開發中產品,主要的財務相關交易的最新資訊等等,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 報告的內容
  • 生物性骨材市場區分
  • 該報告針對的市場定義

第3章 韓國生物性骨材市場

  • 收益(實際成果)
  • 收益(預測)
  • 銷售數(實際成果)
  • 銷售數(預測)
  • 平均價格
  • 流通佔有率:各收益
  • 企業佔有率:各收益

第4章 主要企業概要

  • Korea Bone Bank Inc.
  • DePuy Companies
  • Sanofi
  • Stryker Corporation
  • Biomet, Inc.
  • Medtronic, Inc.

第5章 開發中產品

第6章 財務交易情勢

  • 資本交易
  • 聯盟

第7章 最近的趨勢

  • 法律規章

第8章 附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDMECC1145DB

GlobalData's new report, "South Korea Orthobiologics Market Outlook to 2021", provides key market data on the South Korea Orthobiologics market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market segments - Bone Graft and Substitutes, Viscosupplementation and Bone Growth Stimulators.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size for Orthobiologics market categories - Bone Graft and Substitutes, Viscosupplementation and Bone Growth Stimulators.
  • Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
  • 2014 company shares and distribution shares data for Orthobiologics market.
  • Global corporate-level profiles of key companies operating within the South Korea Orthobiologics market.
  • Key players covered include DePuy Companies, Sanofi, Medtronic, Inc., NuVasive, Inc., Biomet, Inc., Smith & Nephew Plc, Baxter International Inc., Wright Medical Group, Inc. and Stryker Corporation.

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About?
  • 2.2. Orthobiologics Market Segmentation
  • 2.3. Definitions of Markets Covered in the Report

3. Orthobiologics Market, South Korea

  • 3.1. Orthobiologics Market, South Korea, Revenue ($m), 2007-2014
  • 3.2. Orthobiologics Market, South Korea, Revenue ($m), 2014-2021
    • 3.2.1. Bone Grafts and Substitutes Market, South Korea, Revenue ($m), by Segment, 2007-2014
    • 3.2.2. Bone Grafts and Substitutes Market, South Korea, Revenue ($m), by Segment, 2014-2021
  • 3.3. Orthobiologics Market, South Korea, Volume (Units), 2007-2014
  • 3.4. Orthobiologics Market, South Korea, Volume (Units), 2014-2021
    • 3.4.1. Bone Grafts and Substitutes Market, South Korea, Volume (Units), by Segment, 2007-2014
    • 3.4.2. Bone Grafts and Substitutes Market, South Korea, Volume (Units), by Segment, 2014-2021
  • 3.5. Orthobiologics Market, South Korea, Average Price ($), 2007-2021
  • 3.6. Orthobiologics Market, South Korea, Distribution Share by Revenue ($m), 2013-2014
  • 3.7. Orthobiologics Market, South Korea, Company Share by Revenue ($m), 2014

4. Overview of Key Companies in South Korea, Orthobiologics Market

  • 4.1. Cellumed Co. Ltd.
    • 4.1.1. Company Overview
  • 4.2. DePuy Companies
    • 4.2.1. Company Overview
  • 4.3. Medtronic plc
    • 4.3.1. Company Overview
  • 4.4. Seikagaku Corporation
    • 4.4.1. Company Overview
  • 4.5. Arthrex, Inc.
    • 4.5.1. Company Overview
  • 4.6. Bloomage Freda Biopharm Co., Ltd
    • 4.6.1. Company Overview
  • 4.7. Qingdao Haitao Biochemical Co.,Ltd
    • 4.7.1. Company Overview
  • 4.8. Stryker Corporation
    • 4.8.1. Company Overview
  • 4.9. Sanofi
    • 4.9.1. Company Overview
  • 4.10. Chugai Pharmaceutical Co., Ltd.
    • 4.10.1. Company Overview
  • 4.11. Foretek Microsystem Co., Ltd.
    • 4.11.1. Company Overview

5. Orthobiologics Market Pipeline Products

6. Recent Developments

  • 6.1. Other Significant Developments
    • 6.1.1. Feb 10, 2015: The biggest R&D investment in 2014, 20.0% of sales revenue

7. Appendix

  • 7.1. Research Methodology
    • 7.1.1. Coverage
    • 7.1.2. Secondary Research
    • 7.1.3. Primary Research
    • 7.1.4. Market Modeling and Forecasting
    • 7.1.5. Company Share Analysis
    • 7.1.6. Distribution Share Analysis
  • 7.2. Expert Panel
  • 7.3. GlobalData Consulting
  • 7.4. Contact Us
  • 7.5. Disclaimer

List of Tables

  • Table 1: Orthobiologics Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 2: Orthobiologics Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 3: Bone Grafts and Substitutes Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 4: Bone Grafts and Substitutes Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 5: Orthobiologics Market, South Korea, Volume (Units), Historic, 2007-2014
  • Table 6: Orthobiologics Market, South Korea, Volume (Units), Forecast, 2014-2021
  • Table 7: Bone Grafts and Substitutes Market, South Korea, Volume (Units), Historic, 2007-2014
  • Table 8: Bone Grafts and Substitutes Market, South Korea, Volume (Units), Forecast, 2014-2021
  • Table 9: Orthobiologics Market, South Korea, Average Price ($) Historic, 2007-2014
  • Table 10: Orthobiologics Market, South Korea, Average Price ($), Forecast, 2014-2021
  • Table 11: Orthobiologics Market, South Korea, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 12: Orthobiologics Market, South Korea, Company Share by Revenue ($m), USD Constant, 2014
  • Table 13: Orthobiologics Market Pipeline Products
  • Table 14: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country

List of Figures

  • Figure 1: Orthobiologics Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 2: Orthobiologics Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 3: Bone Grafts and Substitutes Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 4: Bone Grafts and Substitutes Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 5: Orthobiologics Market, South Korea, Volume (Units), Historic, 2007-2014
  • Figure 6: Orthobiologics Market, South Korea, Volume (Units), Forecast, 2014-2021
  • Figure 7: Bone Grafts and Substitutes Market, South Korea, Volume (Units), Historic, 2007-2014
  • Figure 8: Bone Grafts and Substitutes Market, South Korea, Volume (Units), Forecast, 2014-2021
  • Figure 9: Orthobiologics Market, South Korea, Company Share (%) 2014
  • Figure 10: GlobalData Epidemiology-Based Forecasting Model
  • Figure 11: GlobalData Capital Equipment-Based Forecasting Model
  • Figure 12: Primary Interviews by Participant Type (%)
Back to Top